Post-COVID-19 Burden of Communicable Diseases
摘要
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, which began in February 2021, has cost healthcare systems and society around the world a great deal of money and caused over 110 million infected cases and about 2.5 million fatalities. A person suffering from any communicable disease is more prone towards the SARS-CoV-2 infection. The COVID-19 pandemic has precipitated a profound reconfiguration of infectious disease epidemiology. Global surveillance data indicates substantial shifts in transmission patterns, healthcare utilization, and disease prevalence across multiple infectious disease categories. It covers a vast range of communicable diseases, including those transmitted through faecal-oral, sexually transmitted, blood-borne, vector-borne, and airborne routes. It also includes information on diseases transmitted through skin wounds, contaminated food or water, and direct contact. Regarding the COVID-19 pandemic, this table highlights how certain communicable diseases, such as Hepatitis A, Hepatitis B, and Viral meningitis, are considered lower in comparison, while others, like Legionellosis, are higher in severity. The post-pandemic era has transformed infectious disease dynamics across respiratory, vector-borne, sexually transmitted, and vaccine-preventable diseases. Respiratory infections like influenza and RSV show complex transmission patterns influenced by pandemic measures and improved hygiene practices. Vector-borne diseases, such as malaria and dengue, are spreading to new regions due to climate change and ecological shifts. Sexually transmitted infections, including HIV and syphilis, faced setbacks from reduced testing, while telemedicine emerged as a critical tool for management. Vaccine-preventable diseases saw declining immunization rates, exposing gaps in healthcare equity and trust. The pandemic has severely impacted low-income migrant workers, with many facing economic hardship. Disturbing images of migrant workers walking home during the lockdown sparked significant debate. Future strategies must focus on developing resilient and adaptive healthcare systems promptly capable of responding to evolving threats. Addressing social determinants of health poverty, education, and access to basic services remains critical for reducing vulnerabilities.